A new era of precision medicine: The unprecedented impact of generative AI across the precision medicine landscape
Precision medicine (PM), a paradigm-shifting model in healthcare and life sciences, is focused on delivering tailored treatments and prevention strategies to individual patients. As this important clinical discipline continues to evolve, artificial intelligence (AI), and more specifically generative AI, will likely serve as the cornerstone of innovation and accelerator of progress.
The industry however must address several hurdles to drive AI’s broader adoption, including mitigating issues surrounding data privacy, ethical implications, regulatory approvals, and infrastructure investments. By addressing these challenges, fostering trust in AI, and nurturing talent in the field, we can pave the way for a future where AI and PM converge to deliver more rapid, patient-centric, and personalized healthcare interventions.
A new era of precision medicine
Download PDFOur professionals immerse themselves in your organization, applying industry knowledge, powerful solutions and innovative technology to deliver sustainable results. Whether it’s helping you lead an ESG integration, risk mitigation or digital transformation, KPMG creates tailored data-driven solutions that help you deliver value, drive innovation and build stakeholder trust.